Tumors of the Central Nervous System, Volume 5 (Record no. 104364)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 05856nam a22005415i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 978-94-007-2019-0 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20140220083339.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 110926s2012 ne | s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9789400720190 |
| -- | 978-94-007-2019-0 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/978-94-007-2019-0 |
| Source of number or code | doi |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC261-271 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MJCL |
| Source | bicssc |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED062000 |
| Source | bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 614.5999 |
| Edition number | 23 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Hayat, M.A. |
| Relator term | editor. |
| 245 10 - TITLE STATEMENT | |
| Title | Tumors of the Central Nervous System, Volume 5 |
| Medium | [electronic resource] : |
| Remainder of title | Astrocytomas, Hemangioblastomas, and Gangliogliomas / |
| Statement of responsibility, etc | edited by M.A. Hayat. |
| 264 #1 - | |
| -- | Dordrecht : |
| -- | Springer Netherlands, |
| -- | 2012. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | XXVI, 290 p. |
| Other physical details | online resource. |
| 336 ## - | |
| -- | text |
| -- | txt |
| -- | rdacontent |
| 337 ## - | |
| -- | computer |
| -- | c |
| -- | rdamedia |
| 338 ## - | |
| -- | online resource |
| -- | cr |
| -- | rdacarrier |
| 347 ## - | |
| -- | text file |
| -- | |
| -- | rda |
| 490 1# - SERIES STATEMENT | |
| Series statement | Tumors of the Central Nervous System ; |
| Volume number/sequential designation | 5 |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Introduction. Part 1. ASTROCYTOMAS. DIAGNOSIS AND BIOMARKERS -- 1. Methylation in malignant astrocytomas -- 2. Deciphering the function of doppel protein in astrocytomas -- 3. Astrocytic tumors: role of antiapoptotic proteins -- 4. Astrocytomas: role of wnt/β- catenin/tcf signaling pathway -- 5. Subependymal giant cell astrocytoma: role of mtor pathway -- 6. Role of progesterone preceptor isoforms in human astrocytomas growth -- 7. Astrocytic tumors: role of carbonic anhydrase ix -- 8. Development of cysts in pilocytic astrocytomas: role of eosinophilic granular bodies (method) -- 9. Role of synemin in astrocytoma cell migration -- 10. Diffuse astrocytomas: immunohistochemistry of mgmt expression.-11. Central nervous system germ cell tumors: an epidemiology review -- 12. Raf genes and mapk activation in pilocytic astrocytomas -- 13. Biomarker discovery in central nervous system neoplasms: past, present and future -- 14. Astrocytomas: role of taurine in apoptosis using magnetic resonance spectroscopy -- 15. Imaging of hypoxia-inducible factor-1-active regions in tumors using a pos and 123i-ibb method -- 16. Diffuse low-grade astrocytomas: p53-mediated inhibition of angiogenesis -- 17. Spontaneous regression of cerebellar astrocytomas mansoor foroughi, shibu pillai, and paul steenbok -- 18. Subependymal giant cell astrocytoma: gene expression profiling magdalena ewa tyburczy and bozena kaminska. THERAPY. - 19. Time- resolved laser induced fluorescence spectroscopy (trlifs): a tool for intra-operative diagnosis of brain tumors and maximizing extent of surgical resection -- 20. Magnetic resonance-guided laser interstitial thermal therapy for brain tumors -- 21. Nanotechnology-based therapy for malignant tumors of the central nervous system -- 22. Pilocytic astrocytoma: pthological and immunohistochemical factors affecting surgical treatment and surveillance -- 23. Pilomyxoid astrocytoma: chemotherapy hitoshi tsugu, shinya oshiro, fuminari komatsu, hiroshi abe, takeo fukushima, tooru inoue, fumio yanai, yuko nomura. PROGNOSIS -- 24. Astrocytomas: predicting survival and recurrence using cerebral blood volume measurements.-25. Electronic patient-reported outcome monitoring (eprom) in brain tumour patients. Part 2. HEMANGIOBLASTOMA -- 26. Intra-operative icg use in the management of hemangioblastomas -- 27. Hemangioblastoma cysts: diagnosis using fluorescence with 5-aminolevulinic acid -- 28. Hemangioblastoma-stereotactic radiosurgery anand veeravagu, bowen jiang, and steven chang. Part 3.GANGLIOGLIOMA -- 29. Gangliogliomas: molecular pathogenesis and epileptogenesis eleonora aronica and pitt niehusmann -- 30. Epilepsy-associated gangliogliomas: identification of genes with altered expression. Index. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | The most recent developments in diagnostic and therapeutic aspects of Gliomas (glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers (determined by molecular genetics) is included, along with their advantages and limitations as markers in tumor detection and diagnosis. The identification and validation of brain cancer (glioblastoma) genes are discussed. The role of cancer stem cells in the initiation and persistence of malignant gliomas is explained; response of glioblastoma cancer stem cells to various growth factors, such as epidermal growth factor receptor kinase inhibitor, is explained. The use of surgical resection, chemotherapy (e.g., temozolomide), immunotherapy, and radiation therapy for glioblastoma patients is included. Biological impediments for chemotherapy and radiotherapy for malignant glioblastoma are pointed out. Standard (established) as well as newer imaging modalities (proton magnetic resonance spectroscopy) are discussed. Also included are proton magnetic resonance spectroscopy in intracranial gliomas, and the use of proton magnetic spectroscopic imaging in determining the infiltration zone in gliomas. The role of molecular signaling in the CNS cancer development is explained, including cell death signaling in glioblastoma multiforme. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medicine. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Oncology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Radiology, Medical. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Neurosurgery. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Pathology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Surgery. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Biomedicine. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Cancer Research. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Neuroradiology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Neurosurgery. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Oncology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Surgery. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Pathology. |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY | |
| Title | Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Display text | Printed edition: |
| International Standard Book Number | 9789400720183 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Tumors of the Central Nervous System ; |
| Volume number/sequential designation | 5 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | http://dx.doi.org/10.1007/978-94-007-2019-0 |
| 912 ## - | |
| -- | ZDB-2-SBL |
No items available.